Hypertension & Nephrology Association

Eatontown, New Jersey 07724

2 studies enrolling now · 2 studies all time

What they study most

End Stage Kidney Disease, Obesity, Overweight

Studies at this site

• A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes — Recruiting now
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now